BIC LEN HIV Treatment: New Single-Tablet Regime...

By João L. Carapinha

February 26, 2026

BIC/LEN HIV Treatment Maintains Suppression in Switch Studies Phase 3 results from Gilead Sciences' ARTISTRY-1 and ARTISTRY-2 trials, presented at the 2026 Conference on R...
NICE Approves Ruxolitinib Cream for Treating Vitiligo with Facial Involvement
SAHPRA GMP Compliance: Addressing Allegations Against Adcock Ingram’s C...
Economic Impact of Industry Clinical Trials in Europe
Enhancing Systematic Reviews: AI Literature Review Integration for Efficiency...
Administrative Court Error Complicates Infarmed Vaccine Data Transparency
EMA Validation of ENHERTU Breast Cancer Treatment for Post-Neoadjuvant Therapy
NICE Updates Type 2 Diabetes Guidelines: Emphasizing Cardiorenal Protection w...
Enhancing Safety and Performance: The Role of EU Medical Device Panels
European Commission Approves Enhanced Wegovy Obesity Treatment Dose
Genotype ECG Prediction
NICE Endorses Pegzilarginase for Treating Arginase Deficiency
Advancing Cancer Screening in Slovenia: A Pathway to Equitable Care